Topic List : Cancer
No survival benefit with new cancer drug
Cisplatin chemotherapy can bring lasting adverse health effects, but a new, presumably less-toxic alternative is not as effective at promoting survival, according to a large, Stanford-led trial.
Study: Anti-CD47 cancer therapy safe
An immunotherapy conceived at Stanford appeared safe in an early clinical trial. Half of the participants responded positively to the treatment, aimed at triggering macrophages to engulf cancer cells, the researchers reported.
Clue charting cancer gene regulation
Understanding when and where proteins bind to DNA may be the ticket to identifying cancer at the cellular level, according to researchers at Stanford.
Artandi to lead Stanford Cancer Institute
A cancer biologist, Artandi studies the role of telomerase in stem cells and cancer. He replaces outgoing director Beverly Mitchell.
‘Cascade’ testing identifies relatives at risk
An online effort coupled with lower costs significantly increased the proportion of cancer patients’ relatives who chose to undergo genetic testing for cancer-associated mutations in Stanford study.
Test predicts lymphoma therapy success
Changes in circulating tumor DNA levels quickly predict how patients with diffuse large B cell lymphoma are responding to therapy, according to a Stanford-led study. Currently, patients wait months for the results.
Common skin cancer linked to other cancers
Frequent skin cancers due to mutations in genes responsible for repairing DNA are linked to a threefold risk of unrelated cancers, according to a Stanford study. The finding could help identify people for more vigilant screening.
How a magnetized wire attracts tumor cells
Scientists at Stanford used the wire to capture free-floating tumor cells in the blood, a technique that soon could be used in humans to yield an earlier cancer diagnosis.
D-limonene could offset dry mouth in cancer patients
A Stanford collaboration between clinical and basic science researchers has led to the identification of a compound that could improve the quality of life for head and neck cancer patients.
PET tracer predicts success of cancer ‘vaccine’
With a radioactive tracer, scientists can use a PET scan to quickly tell whether a cancer immunotherapy will be effective or not, according to a new Stanford study.